Omega Healthcare Investors Inc. (OHI) Stock Analysis
Market Closed
Sector: Real Estate · Industry: Real Estate Investment Trusts
AnalystsHold24 analystsWhat's happening with OHI
Price History
5-Year Weekly Candlestick Chart
Profile
growth and valuation lag behind.
How is each axis scored?
- Valuation45/100 · Weak
- P/E vs own history (36th pct)20/25
- FCF yield (n/a)10/25
- P/S (11.4x)5/25
- EV/EBIT (n/a)10/25
- Growth36/100 · Weak
- Revenue CAGR (2.9%)6/25
- Net income CAGR (9.1%)12/25
- EPS CAGR 5Y (2.6%)6/25
- Fwd implied growth (5.7%)12/25
- Profitability62/100 · Moderate
- ROIC (n/a)0/25
- ROE (12.2%)12/25
- Net margin (51.1%)25/25
- Operating margin (42.6%)25/25
- Financial Health52/100 · Moderate
- Altman Z (2.57)18/25
- Current ratio (0.91)6/25
- Interest coverage (1.7x)3/25
- Net cash / debt (Net cash)25/25
- Quality55/100 · Moderate
- Piotroski F (5/9)15/25
- Beneish M (-2.50)20/25
- FCF conversion (n/a)0/25
- Margin stability (σ 6.0%)20/25
About Omega Healthcare Investors Inc.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U. Show more
S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
Headquarters: HUNT VALLEY, MD · Employees: 69 · Website ↗
Insider Transactions
Recent SEC Form 4 filings
- SellGift · filed 2026-08-11-5131 sh2026-08-07
- SellDisposition · filed 2026-07-01-11 sh2026-07-01
- BuyGrant / award · filed 2026-07-01+168 sh2026-07-01
- BuyOption exercise · filed 2026-07-01+5.6K sh2026-06-30
- BuyOption exercise · filed 2026-07-01+14.9K sh2026-06-30
+3 more recent filings
Key Metrics
Financial snapshot — pillar inputs plus per-share and market context
Valuation
45D+P/E (TTM)23.6xB
Grade B: FairPrice / TTM EPS (own statements) — vs own 5Y history: 13.5x–35.6x · 36th pct
P/FCF26.6xB
Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield3.8%C
Grade C: LowTTM FCF / Market Cap
P/S (TTM)11.38xD
Grade D: ExpensivePrice / TTM Revenue (own statements) — vs own 5Y history: 5.8x–13.4x · 78th pct
EV/EBITDA19.6xC
Grade C: ExpensiveEnterprise value / EBITDA (Finnhub) — capital-structure neutral
EV/Sales14.1xD
Grade D: Very expensiveEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E22.3xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio2.71xA
Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio0.22A
Grade A: CheapFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield5.64%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio132.2%D
Grade D: UnsustainableDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
62BROIC—
NOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE12.2%C
Grade C: AverageReturn on Equity. Neg. equity = heavy buybacks
ROA8.4%C
Grade C: AverageReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin51.1%A
Grade A: HighNet Income / Revenue
Operating Margin—
TTM EBIT / TTM Revenue
Gross Margin98.8%A
Grade A: PremiumGross Profit / Revenue
FCF Margin—
FCF / Revenue
True FCF Margin—
TTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Financial Health
52CAltman Z-Score2.57C
Grade C: Gray zoneBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio0.91xD
Grade D: LowCurrent Assets/Liabilities
Quick Ratio0.91xC
Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage1.7xD
Grade D: RiskyEBIT/Interest. >10 Strong
Debt Repayment—
Years to repay net debt via FCF
Net Debt/EBIT—
Leverage. <2x Low, >4x High
Debt/Equity0.82xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt—
Cash covers how much of total debt. >1 = could repay all debt from cash
Growth
36DRevenue CAGR2.9%D
Grade D: LowCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR9.1%C
Grade C: OkCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)2.6%D
Grade D: LowCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth5.7%B
Grade B: LowImplied 1Y EPS growth from forward P/E vs our TTM EPS. Sparse — only where forward estimates exist
Dilution (5Y)+38.6%D
Grade D: DilutiveShare count change over 5Y
SBC / Net Income6.2%A
Grade A: LowStock-based comp/Net income. >30% = dilution risk
SBC / Revenue3.2%C
Grade C: MedTTM stock-based comp / TTM Revenue
Quality
55CPiotroski F-Score5/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-2.50A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion—
FCF / Net Income
Margin Stability6.0%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue—
TTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.12xD
Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
More metrics — Per Share, Balance Sheet, MarketHide additional metrics
Per Share
EPS (TTM)$1.97
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$0.09
Cash & short-term investments per share (Finnhub)
Book Value / Share$17.53
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt—
Total debt obligations (short + long term)
Cash & Equiv.$26.15M
Cash and short-term investments
Net Debt—
Total Debt minus Cash. Negative = Net Cash position
Total Equity$5.19B
Shareholders' equity (book value)
Asset / Liability2.14xA
Grade A: SolidTotal Assets / Total Liabilities
Market
Market Cap$14.07B
Current Market Capitalization
Beta0.57B
Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
Takeaway
Current P/E of 23.6x sits at the 36th percentile of its historical range.
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Mar 2026 · Ratio snapshot Sep 25, 2026
Key Insights: Omega Healthcare Investors Inc. (OHI)
Piotroski F-Score of 5/9 indicates mixed fundamentals for Omega Healthcare Investors Inc.. Altman Z-Score of 2.57 falls in the grey zone (1.81–2.99) — financial distress is unlikely but not ruled out. Beneish M-Score of -2.50 suggests a low likelihood of earnings manipulation.
- Interest coverage of 1.7× leaves little room for earnings shocks.
- The stock currently yields 5.6% in dividends.
See how OHI ranks on the Capex Tracker — top 50 capital spenders compared.
No significant market moves for OHI in the last 30 days.
See OHI move history →Frequently Asked Questions about OHI
Is OHI stock a buy right now?
PreMarketPrice's quantitative model rates Omega Healthcare Investors Inc.'s financial health at 52/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is OHI stock overvalued?
Omega Healthcare Investors Inc. trades at a trailing P/E of 23.6 and our valuation score rates it 45/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Omega Healthcare Investors Inc. report earnings?
No confirmed earnings date is currently scheduled for OHI. The Earnings section lists recent reports and updates as dates are announced.
What sector does Omega Healthcare Investors Inc. operate in?
Omega Healthcare Investors Inc. operates in the Real Estate sector, within the Real Estate Investment Trusts industry. The Related Stocks section lists sector peers for comparison.
What does Omega Healthcare Investors Inc. do?
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.
About Omega Healthcare Investors Inc. (OHI) Stock
Omega Healthcare Investors Inc. (OHI) is a US-listed stock operating in the Real Estate sector, specifically the Real Estate Investment Trusts industry. Real-time pricing data for Omega Healthcare Investors Inc. is available on this page with a market capitalization of $14.1 billion. The financial health score for OHI is 52/100, which indicates moderate financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for OHI stock.
OHI Stock Analysis & Key Metrics
On PreMarketPrice, you can track Omega Healthcare Investors Inc. (OHI) across multiple dimensions:
- Pre-market price & movement: Real-time OHI stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for OHI with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Omega Healthcare Investors Inc. across multiple reporting periods.
- Financial health score: A composite score of 52/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for OHI.
- Sector peers: Compare OHI against 10 other real estate stocks on key financial metrics.
Is OHI a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Omega Healthcare Investors Inc. (OHI) as an investment. The financial health score of 52/100 suggests moderate financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Omega Healthcare Investors Inc. (OHI) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.